These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 7470869)

  • 1. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of regional brain dopamine systems to haloperidol.
    Kolenik SA; Hoffman FJ; Bowers MB
    Biol Psychiatry; 1989 Mar; 25(6):815-7. PubMed ID: 2923943
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Wheeler SC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus.
    Jaskiw GE; Weinberger DR; Crawley JN
    Biol Psychiatry; 1991 Apr; 29(7):703-6. PubMed ID: 1711381
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N; Nakahara D; Miura H; Kasahara Y; Nagatsu T
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y; Oki K; Segawa T
    J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
    Westerink BH; Kikkert RJ
    J Neurochem; 1986 Apr; 46(4):1145-52. PubMed ID: 3950621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol-preferring rats: genetic sensitivity to alcohol-induced stimulation of dopamine metabolism.
    Fadda F; Mosca E; Colombo G; Gessa GL
    Physiol Behav; 1990 Apr; 47(4):727-9. PubMed ID: 2385646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral neurochemical changes induced by unilateral cerebral haloperidol administration: evidence for cerebral asymmetry in the rat.
    Hyde JF; Jerussi TP
    Pharmacol Biochem Behav; 1992 Jul; 42(3):457-64. PubMed ID: 1409779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spontaneous ingestion of ethanol on brain dopamine metabolism.
    Fadda F; Mosca E; Colombo G; Gessa GL
    Life Sci; 1989; 44(4):281-7. PubMed ID: 2915601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
    Kito S; Shimoyama M; Arakawa R
    Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J; Coviella IL; Wurtman RJ
    Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.